FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/03/2024
Voltar para busca
Dado oficial do USPTO
LEEZOVI
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: Estados Unidos
Snapshot rápido
LEEZOVI
ST13
US500000079362721Classe
1, 5, 42, 44
Pedido
79362721
Registro
7215591
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
33
Atualização mais recente
12/03/2024
Tipo de marca
Verbal
Classes Nice
1, 5, 42, 44
Data de depósito
28/07/2022
Data de registro
14/11/2023
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
14/11/2023
Última transação
14/11/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
DE
Examinador
LEIPZIG, MARC
Unidade examinadora
M60
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Miltenyi Biotec B.V. & Co. KG
Representantes
Michelle J. Levin Leason Ellis LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicalbiological and biochemical products for industrialscientificdiagnostic purposesbiological tissue culturesdiagnostic preparations for scientific use; Chemical preparations for use in separation processes for biological materials; reagents for scientific and research usereagents for cell separationlabeling reagentsreagents for the preparation of mediaall for commercial and scientific purposes and for the use in medical laboratories; chemical reagentsother than for medical or veterinary purposes with magnetic beads; chemical antibody reagentsother than for medical or veterinary purposes; buffer solutions for scientific purposes in analytical chemistry and chemical reagentsfor non-medical purposesfor use with laboratory instrumentsespecially separation instrumentschemical analysis instrumentsreactors and imaging instruments; reagentsother than for medical or veterinary purposesfor processing of biological materialespecially tissuebone marrowcellsblood; diagnostic reagents and preparations for scientific purposes and for use in medical laboratories; cell culture mediafor in-vivo imagingall for scientific purposes; chemical reagents for non-medical purposesfor use in biotechnologyin biological treatment processes and in the biotechnology industry
Classe 5
Pharmaceutical preparations for use in treating cancer or autoimmune diseases; veterinary preparations for use in treating cancer or autoimmune diseases in household animals and horses; medicinal preparations for cancer or autoimmune diseases; Reagents and media for medical and veterinary diagnostic purposes; diagnostic reagents for medical use and veterinary diagnostic reagentsreagents containing magnetic beadsantibody reagents and reagents for the processingseparationisolationenrichmentdepletiondetectionscreeninganalysis and counting of materialespecially of biological materials; Reagents for medical use and clinical medical reagentsreagents for use with medical instrumentsespecially separation instrumentsanalysis instrumentsreactor and imaging instruments; reagents for the processing of biological materialespecially tissuebone marrowcellsblood and its componentsall for medical or veterinary purposes; Media for bacteriological cultures; diagnostic reagents and preparations for medical and veterinary purposes; contrast agents for in-vivo imagingall for medical and veterinary purposes; pharmaceutical preparations for cellular therapy
Classe 42
Medicalpharmaceutical and biotechnological laboratory services; medical laboratory services and laboratory research services relating to pharmaceuticalsin particular in connection with the manufacture of cell therapeutic agentscell compoundscellular medicinesfeaturing the selectionstimulationactivation of cellsas well as the manufacture of medical and scientific kits and reagents
Classe 44
Medical servicesin particular the field of extracorporeal plasma therapy; medical treatment servicesmedical treatment of cancer or autoimmune diseases
Publicações
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
21/02/2024
FIMP
FINAL DISPOSITION PROCESSED
21/02/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
14/02/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
14/11/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
14/11/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
29/08/2023
PUBO
PUBLISHED FOR OPPOSITION
29/08/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/08/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
26/07/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
26/07/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/07/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
26/07/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
24/07/2023
GNRT
NON-FINAL ACTION E-MAILED
24/07/2023
CNRT
NON-FINAL ACTION WRITTEN
24/07/2023
RFNT
REFUSAL PROCESSED BY IB
22/07/2023
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
19/07/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
28/06/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
28/06/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
28/06/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
28/06/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
28/06/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
28/06/2023
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
24/06/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
21/06/2023
RFRR
REFUSAL PROCESSED BY MPU
21/06/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
17/05/2023
CNRT
NON-FINAL ACTION WRITTEN
16/05/2023
DOCK
ASSIGNED TO EXAMINER
16/05/2023
MAFR
APPLICATION FILING RECEIPT MAILED
21/02/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/02/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
16/02/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LEEZOVI ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.